Skip to main content

Atyr Pharma Inc(LIFE-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment

Globe Newswire - Tue Jun 14, 2022

Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair.

Second tRNA synthetase receptor identified from company’s platform.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe